Clinical, Molecular, and Genomic Changes in Response to a Left Ventricular Assist Device

Jennifer L. Hall(American Heart Association), Leslie W. Miller(University of Minnesota), Peter Eckman(Abbott Northwestern Hospital), Emma J. Birks(Lung Institute), Jeremias Wohlschlaeger(DIAKO), Paul J.R. Barton(Guy's and St Thomas' NHS Foundation Trust), Hideo A. Baba(Essen University Hospital), David Fermin(Mayo Clinic), Mark S. Slaughter(University of Louisville)
Journal of the American College of Cardiology
February 1, 2011
10.1016/j.jacc.2010.11.010
Cited by 127

Related Papers

Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
|Nature|2010|1.2k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711